PFE financials
Pfizer (PFE) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
PFE income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $62.58B | $46.51B | $17.41B | $7.77B | 1.36 |
| 2024 | $63.63B | $45.78B | $14.94B | $8.03B | 1.41 |
| 2023 | $59.55B | $34.60B | $4.42B | $2.12B | 0.37 |
| 2022 | $101.17B | $66.83B | $38.12B | $31.37B | 5.47 |
| 2021 | $81.29B | $50.47B | $20.23B | $21.98B | 3.88 |
| 2020 | $41.65B | $33.17B | $8.83B | $9.16B | 1.63 |
- PFE revenue was $62.58B in fiscal 2025, net income $7.77B.
Updated 2026-11-02 17:54 UTC